| Translated title of the contribution | Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk |
|---|---|
| Original language | English |
| Pages (from-to) | 881 - 890 |
| Number of pages | 10 |
| Journal | Diabetologia |
| Volume | 49 (5) |
| DOIs | |
| Publication status | Published - May 2006 |
Bibliographical note
Publisher: SpringerUN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver